Tag Archives: Salix Pharmaceuticals Ltd. (NASDAQ:SLXP)

Find Out Before You Trade: Salix Pharmaceuticals (SLXP), Celgene (CELG), Boston Scientific (BSX)

Albany, New York (09/25/2014) – Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has reportedly been approached by Actavis PLC (ACT) for buyout talks. The news...

News Recap: Liquidmetal Technologies Inc (LQMT), Salix Pharmaceuticals, Ltd. (SLXP), Acceleron Pharma Inc (XLRN), Alco Stores Inc (ALCS)

Albany, New York (09/24/2014) – Liquidmetal Technologies Inc (OTCBB:LQMT) announced the schedule of its 2014 shareholders meeting. It will be held on...

Pfizer Inc

Pfizer Inc. (NYSE:PFE) Exploring Ways Of Tax Reduction; Approaches Actavis Plc (NYSE:ACT) For Takeover

Albany, New York (09/24/2014) – Pfizer Inc. (NYSE:PFE) has reportedly approached Actavis plc (NYSE:ACT) for its acquisition to find ways of reducing...

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)’s Xifaxan 550 sNDA Under Review, Response in Expected By February 28, 2015

Albany, New York (09/22/2014) – Supplemental new drug application (sNDA) for Xifaxan 550 of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has been accepted...